Pure Global
NCT06014008

Effect of L. Paracasei Strain Shirota on Constipation in Healthy US Adults

The Effect of Lacticaseibacillus Paracasei Strain Shirota (LcS) in Healthy US Individuals Suffering From Hard or Lumpy Stools: A Randomized Controlled Open Trial.
Yakult U.S.A. Inc.·ClinicalTrials.gov·otherNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Constipation
Drug/Device/Intervention
Test product consumption group
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Yakult U.S.A. Inc.
Timeline & enrollment
Phase
N/A
Start date
Aug 01, 2023
End date
Aug 01, 2024
Enrollment
50 participants
Primary outcome

Proportion of subjects that produce hard or lumpy stools (Subjectively evaluated Bristol stool form scale (BSFS) score of 1 or 2, ) ≥ 25% of bowel movements.

Summary

The objective of this study is to investigate the efficacy of daily consumption of a
 fermented milk containing LcS in reducing the frequency of bowel movement with hard or lumpy
 stools in generally healthy U.S. adult population with intermittent bowel movements producing
 hard or lumpy stools.

ICD-10 classifications
ConstipationIrritable bowel syndrome with predominant constipation [IBS-C]Other laxativesPoisoning: Other laxativesOther functional intestinal disorders
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06014008
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06014008 through Pure Global AI's free database. This phase not specified trial is sponsored by Yakult U.S.A. Inc. and is currently Not yet recruiting. The study focuses on Constipation. Target enrollment is 50 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.